Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C9H14N4O4
CAS Number:
Molecular Weight:
242.23
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
MDL number:
InChI
1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3/b10-8-
SMILES string
CCOC(=O)N=C1O[N-][N+](=C1)N2CCOCC2
InChI key
XLFWDASMENKTKL-NTMALXAHSA-N
grade
pharmaceutical primary standard
API family
molsidomine
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
Looking for similar products? Visit Product Comparison Guide
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Molsidomine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Acute Tox. 4 Oral
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
[Pharmacology of molsidomine and its active metabolites].
E Böhme
Medizinische Klinik (Munich, Germany : 1983), 85 Suppl 1, 7-10 (1990-02-01)
R E Nitz et al.
American heart journal, 109(3 Pt 2), 631-636 (1985-03-01)
The cardioprotective and antithrombotic activity of molsidomine, a novel therapeutic agent for the treatment of coronary heart disease, was investigated in a series of animal models of myocardial ischemia. Molsidomine given to dogs with marked ST segment elevation (epicardial electrogram)
[Molsidomine in the treatment of ischemic heart disease].
S Sterkowicz
Wiadomosci lekarskie (Warsaw, Poland : 1960), 40(20), 1389-1395 (1987-10-15)
J Reden
Blood vessels, 27(2-5), 282-294 (1990-01-01)
Molsidomine is an established drug for the treatment of coronary heart disease. It acts via the metabolite SIN-1 through liberation of NO. Experiments have proven the identity of NO and EDRF. Investigation of the molecular mechanism of action of molsidomine/SIN-1
Effects of molsidomine and other NO-containing vasodilators on cyclic GMP formation.
E Böhme et al.
European heart journal, 4 Suppl C, 19-24 (1983-05-01)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service